These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 11573368)

  • 21. Cost-effectiveness of and satisfaction with a Helicobacter pylori "test and treat" strategy compared with prompt endoscopy in young Asians with dyspepsia.
    Mahadeva S; Chia YC; Vinothini A; Mohazmi M; Goh KL
    Gut; 2008 Sep; 57(9):1214-20. PubMed ID: 18441005
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Functional dyspepsia: definition, classification, clinical and therapeutic management].
    Montalto M; Santoro L; Vastola M; Curigliano V; Cammarota G; Manna R; Gasbarrini G
    Ann Ital Med Int; 2004; 19(2):84-9. PubMed ID: 15317268
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Helicobacter pylori eradication in functional dyspepsia: new evidence for symptomatic benefit.
    Malfertheiner P
    Eur J Gastroenterol Hepatol; 2001 Aug; 13 Suppl 2():S9-11. PubMed ID: 11686231
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [How to diagnose functional (non-ulcerative) dyspepsia (review)].
    Maev IV; B'iuchnova ES; Lebedeva EG; Iakimova SS
    Ter Arkh; 2004; 76(11):57-60. PubMed ID: 15658539
    [No Abstract]   [Full Text] [Related]  

  • 25. Lack of efficacy of cisapride and nizatidine in dyspepsia.
    Adelman A; Alper BS
    J Fam Pract; 1998 Jun; 46(6):457-8. PubMed ID: 9638107
    [No Abstract]   [Full Text] [Related]  

  • 26. Impact of Helicobacter pylori on the management of dyspepsia in primary care.
    Bennett K; Feely J; Thornton O; Dobson M; O'Morain CA; O'Connor HJ
    Aliment Pharmacol Ther; 2006 Aug; 24(4):637-41. PubMed ID: 16907896
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lack of benefit of treating Helicobacter pylori infection in patients with functional dyspepsia. Randomized one-year follow-up study.
    Gisbert JP; Cruzado AI; Garcia-Gravalos R; Pajares JM
    Hepatogastroenterology; 2004; 51(55):303-8. PubMed ID: 15011890
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [What are the results of medical treatments?].
    Chassany O; Douet MC; Ducrot F
    Rev Med Brux; 1999 Apr; 20(2):A115-6. PubMed ID: 10335110
    [No Abstract]   [Full Text] [Related]  

  • 29. [Does Helicobacter pylori infection cause dyspepsia in the absence of ulcer?].
    Gomollón F
    Gastroenterol Hepatol; 2000 Feb; 23 Suppl 2():21-4. PubMed ID: 11968330
    [No Abstract]   [Full Text] [Related]  

  • 30. The management of dyspepsia: a systematic review.
    Delaney B; Moayyedi P; Deeks J; Innes M; Soo S; Barton P; Wilson S; Oakes R; Harris A; Raftery J; Hobbs R; Forman D
    Health Technol Assess; 2000; 4(39):iii-v, 1-189. PubMed ID: 11173308
    [No Abstract]   [Full Text] [Related]  

  • 31. [Comparative study with prokinetic agents. Dyspepsia can be managed with phytotherapy].
    Rösch W; Vinson B; Sassin I
    MMW Fortschr Med; 2002 Jun; 144(24):42. PubMed ID: 12134726
    [No Abstract]   [Full Text] [Related]  

  • 32. Absence of symptomatic benefit of lansoprazole, clarithromycin, and amoxicillin triple therapy in eradication of Helicobacter pylori positive, functional (nonulcer) dyspepsia.
    Veldhuyzen van Zanten S; Fedorak RN; Lambert J; Cohen L; Vanjaka A
    Am J Gastroenterol; 2003 Sep; 98(9):1963-9. PubMed ID: 14499772
    [TBL] [Abstract][Full Text] [Related]  

  • 33. One-week versus two-week H2-receptor antagonist in combination with amoxicillin and tinidazole for eradication of Helicobacter pylori infection.
    Hsu CC; Chen JJ; Hu TH; Lu SN; Changchien CS
    Hepatogastroenterology; 2005; 52(65):1617-21. PubMed ID: 16201128
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Dyspepsia. Investigation and treatment].
    Schmidt VM; Bytzer P
    Ugeskr Laeger; 2001 Sep; 163(37):4990-4. PubMed ID: 11573369
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Meta-analysis: Helicobacter pylori eradication therapy vs. antisecretory non-eradication therapy for the prevention of recurrent bleeding from peptic ulcer.
    Gisbert JP; Khorrami S; Carballo F; Calvet X; Gene E; Dominguez-Muñoz E
    Aliment Pharmacol Ther; 2004 Mar; 19(6):617-29. PubMed ID: 15023164
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Normal gastroscopic findings in dyspepsia are not a contraindication for the administration of gastric acid inhibitors].
    Järhult J; Ulgemo A
    Lakartidningen; 1991 Nov; 88(47):4003-4. PubMed ID: 1683416
    [No Abstract]   [Full Text] [Related]  

  • 37. Treatment of functional dyspepsia.
    Veldhuyzen van Zanten SJ
    Baillieres Clin Gastroenterol; 1998 Sep; 12(3):573-86. PubMed ID: 9890089
    [TBL] [Abstract][Full Text] [Related]  

  • 38. What is the most effective regimen for eradication of Helicobacter pylori in patients who have failed a first eradication attempt?
    Markova T; Schwartz K
    J Fam Pract; 2002 Jan; 51(1):14. PubMed ID: 11927054
    [No Abstract]   [Full Text] [Related]  

  • 39. Systematic review: Antacids, H2-receptor antagonists, prokinetics, bismuth and sucralfate therapy for non-ulcer dyspepsia.
    Moayyedi P; Soo S; Deeks J; Forman D; Harris A; Innes M; Delaney B
    Aliment Pharmacol Ther; 2003 May; 17(10):1215-27. PubMed ID: 12755835
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Approaches to diagnosis and treatment of dyspepsia].
    Jarbøl DE; Kjeldsen HC; Schaffalitzky de Muckadell OB
    Ugeskr Laeger; 2004 Sep; 166(39):3385-8. PubMed ID: 15515390
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.